Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer

Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer

Tumor microenvironment comprises of a variety of cell types, which is quite complex and involved in chemotherapy and immune checkpoint blockage resistance. In order to explore the mechanisms involved in tumor immune microenvironment in pancreatic ductal adenocarcinoma (PDAC), we first constructed an...

Full description

Bibliographic Details
Main Authors:	Hao Qian, Hongzhe Li, Junjie Xie, Xiongxiong Lu, Fanlu Li, Weishen Wang, Xiaomei Tang, Minmin Shi, Linxi Jiang, Hongwei Li, Hao Chen, Chenghong Peng, Zhiwei Xu, Xiaxing Deng, Baiyong Shen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	gene signature immunity pancreatic cancer pancreatic ductal adenocarcinoma prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.682261/full

Similar Items

The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancreas
by: Lihan Qian, et al.
Published: (2020-08-01)

Prognostic Analysis and Influencing Serum Biomarkers of Patients With Resectable Pancreatic Adenosquamous Cancer
by: Yusheng Shi, et al.
Published: (2021-01-01)

Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
by: Haoda Chen, et al.
Published: (2021-06-01)

A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
by: Yangbing Jin, et al.
Published: (2021-03-01)

Accuracy of Nodal Positivity in Inadequate Lymphadenectomy in Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Population Study Using the US SEER Database
by: Weishen Wang, et al.
Published: (2019-12-01)

Does Pre-operative Biliary Drainage Influence Long-Term Survival in Patients With Obstructive Jaundice With Resectable Pancreatic Head Cancer?
by: Ziyun Shen, et al.
Published: (2020-09-01)

Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER‐based analysis of 15,836 cases
by: Ningzhen Fu, et al.
Published: (2021-09-01)

Oncogene APOL1 promotes proliferation and inhibits apoptosis via activating NOTCH1 signaling pathway in pancreatic cancer
by: Jiewei Lin, et al.
Published: (2021-08-01)

Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer
by: Hongzhe Li, et al.
Published: (2017-11-01)

Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma
by: Chenlei Wen, et al.
Published: (2020-10-01)

miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.
by: Tao Li, et al.
Published: (2014-01-01)

Single nucleotide polymorphisms of Toll-like receptor 4 decrease the risk of development of hepatocellular carcinoma.
by: Shi Minmin, et al.
Published: (2011-01-01)

The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility
by: Junjie Xie, et al.
Published: (2012-02-01)

TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells
by: Jian Wu, et al.
Published: (2019-08-01)

Integrated Chromatin Accessibility and Transcriptome Landscapes of Doxorubicin-Resistant Breast Cancer Cells
by: Xuelong Wang, et al.
Published: (2021-07-01)

Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinoma
by: Zengyu Feng, et al.
Published: (2020-09-01)

RER1 enhances carcinogenesis and stemness of pancreatic cancer under hypoxic environment
by: Shi Chen, et al.
Published: (2019-01-01)

Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-05-01)

Clinical efficacy of robot-assisted versus laparoscopic liver resection: a meta analysis
by: Ruoyu Guan, et al.
Published: (2019-01-01)

LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis
by: Hao Zhang, et al.
Published: (2020-09-01)

A Novel Ferroptosis-Related Gene Signature Predicts Recurrence in Patients With Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-09-01)

Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-03-01)

Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer
by: Zhijian Jin, et al.
Published: (2017-12-01)

IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer
by: Guoping Ding, et al.
Published: (2019-11-01)

Perineural Invasion in Pancreatic Cancer: Advanced Research in the Neuro-cancer Interactions
by: Xiao-hong SHEN
Published: (2010-12-01)

Puerarin Ameliorates Caerulein-Induced Chronic Pancreatitis via Inhibition of MAPK Signaling Pathway
by: Xiang-Peng Zeng, et al.
Published: (2021-06-01)

Pancreatic tumor in type 1 autoimmune pancreatitis: a diagnostic challenge
by: Pei Xiang, et al.
Published: (2019-08-01)

An analysis of the 100 most influential articles in the field of pancreatic diseases in the world from 1990 to 2017
by: PENG Li, et al.
Published: (2019-05-01)

GNG12 regulates PD‐L1 expression by activating NF‐κB signaling in pancreatic ductal adenocarcinoma
by: Juan Li, et al.
Published: (2020-02-01)

A Novel DNA Replication-Related Signature Predicting Recurrence After R0 Resection of Pancreatic Ductal Adenocarcinoma: Prognostic Value and Clinical Implications
by: Zengyu Feng, et al.
Published: (2021-03-01)

c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
by: Alexander Lux, et al.
Published: (2019-07-01)

Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer
by: He C, et al.
Published: (2021-09-01)

Autoantibody detection is not recommended for chronic pancreatitis: a cross-sectional Study of 557 patients
by: Xiang-Peng Zeng, et al.
Published: (2019-02-01)

Intelligent Fault-Diagnosis System for Acoustic Logging Tool Based on Multi-Technology Fusion
by: Xiaolong Hao, et al.
Published: (2019-07-01)

Clinical characteristics of acute pancreatitis in children: a single-center experience in Western China
by: Rui Zhong, et al.
Published: (2021-03-01)

PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis
by: Huo Z, et al.
Published: (2019-06-01)

Hic-5 in pancreatic stellate cells affects proliferation, apoptosis, migration, invasion of pancreatic cancer cells and postoperative survival time of pancreatic cancer
by: Baolin Qian, et al.
Published: (2020-01-01)

Colonic hematoma after extracorporeal shock wave lithotripsy for pancreatic stones: a case report
by: Yu Liu, et al.
Published: (2019-12-01)

Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review
by: Qun Chen, et al.
Published: (2021-05-01)

The effect of hospital volume on patient outcomes in severe acute pancreatitis
by: Shen Hsiu-Nien, et al.
Published: (2012-08-01)

Cannot write session to /tmp/vufind_sessions/sess_dejpcps03idtvn7n54iutatebm